Co-Diagnostics, Inc. Cost of Revenue
Co-Diagnostics, Inc. (CODX) reported Cost of Revenue of $45.30 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- Co-Diagnostics, Inc. cost of revenue for the quarter ending 2026-06-30 was $45.30K, a 41.10% increase year-over-year.
- Co-Diagnostics, Inc. cost of revenue for the quarter ending 2026-03-31 was $193.77K, a 797.49% increase year-over-year.
- Co-Diagnostics, Inc. cost of revenue for the quarter ending 2025-12-31 was $142.40K, a 44.17% decline year-over-year.
- Co-Diagnostics, Inc. cost of revenue for the quarter ending 2025-09-30 was $26.29K, a 91.16% decline year-over-year.
- Co-Diagnostics, Inc. cost of revenue for fiscal 2025 was $222.38K, a 77.74% decline from fiscal 2024.
- Co-Diagnostics, Inc. cost of revenue for fiscal 2024 was $999.12K, a 76.13% decline from fiscal 2023.
- Co-Diagnostics, Inc. cost of revenue for fiscal 2023 was $4.18M, a 23.65% decline from fiscal 2022.
- Co-Diagnostics, Inc. cost of revenue for fiscal 2022 was $5.48M, a 52.65% decline from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $45.30K 10-Q · filed 2026-08-13 | $239.07K 10-Q · filed 2026-08-13 | $381.47K derived: sum of 3 quarters · filed 2026-08-13 | $407.75K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | $193.77K 10-Q · filed 2026-05-14 | $336.16K derived: sum of 2 quarters · filed 2026-05-14 | $362.45K derived: sum of 3 quarters · filed 2026-05-14 | $394.56K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | $142.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $168.68K derived: sum of 2 quarters · filed 2026-03-31 | $200.79K derived: sum of 3 quarters · filed 2026-08-13 | $222.38K 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $26.29K 10-Q · filed 2025-11-13 | $58.39K derived: sum of 2 quarters · filed 2026-08-13 | $79.98K 10-Q · filed 2025-11-13 | $335.05K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $32.11K 10-Q · filed 2026-08-13 | $53.70K 10-Q · filed 2026-08-13 | $308.76K derived: sum of 3 quarters · filed 2026-08-13 | $606.17K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $21.59K 10-Q · filed 2026-05-14 | $276.66K derived: sum of 2 quarters · filed 2026-05-14 | $574.06K derived: sum of 3 quarters · filed 2026-05-14 | $786.21K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $255.07K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $552.47K derived: sum of 2 quarters · filed 2026-03-31 | $764.62K derived: sum of 3 quarters · filed 2026-03-31 | $999.12K 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $297.40K 10-Q · filed 2025-11-13 | $509.55K derived: sum of 2 quarters · filed 2025-11-13 | $744.06K 10-Q · filed 2025-11-13 | $3.71M derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $212.15K 10-Q · filed 2025-08-14 | $446.65K 10-Q · filed 2025-08-14 | $3.41M derived: sum of 3 quarters · filed 2025-08-14 | $3.67M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $234.50K 10-Q · filed 2025-05-08 | $3.20M derived: sum of 2 quarters · filed 2025-05-08 | $3.46M derived: sum of 3 quarters · filed 2025-05-08 | $3.92M derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $3.22M derived: sum of 2 quarters · filed 2025-03-27 | $3.68M derived: sum of 3 quarters · filed 2025-03-27 | $4.18M 10-K · filed 2025-03-27 | |||
| 2023-09-30 | $255.77K 10-Q · filed 2024-11-07 | $714.87K derived: sum of 2 quarters · filed 2024-11-07 | $1.22M 10-Q · filed 2024-11-07 | $1.73M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $459.10K 10-Q · filed 2024-08-08 | $961.34K 10-Q · filed 2024-08-08 | $1.48M derived: sum of 3 quarters · filed 2024-08-08 | $2.25M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $502.24K 10-Q · filed 2024-05-09 | $1.02M derived: sum of 2 quarters · filed 2024-05-09 | $1.79M derived: sum of 3 quarters · filed 2024-05-09 | $2.70M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $515.77K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.28M derived: sum of 2 quarters · filed 2024-03-14 | $2.20M derived: sum of 3 quarters · filed 2024-03-14 | $5.48M 10-K · filed 2024-03-14 | $5.48M 10-K · filed 2023-03-16 | ||
| 2022-09-30 | $767.94K 10-Q · filed 2023-11-09 | $1.68M derived: sum of 2 quarters · filed 2023-11-09 | $4.97M 10-Q · filed 2023-11-09 | $7.45M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $915.43K 10-Q · filed 2023-08-10 | $4.20M 10-Q · filed 2023-08-10 | $6.68M derived: sum of 3 quarters · filed 2023-08-10 | $10.00M derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | $3.28M 10-Q · filed 2023-05-11 | $5.77M derived: sum of 2 quarters · filed 2023-05-11 | $9.08M derived: sum of 3 quarters · filed 2023-05-11 | $11.58M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $5.80M derived: sum of 2 quarters · filed 2023-03-16 | $8.30M derived: sum of 3 quarters · filed 2023-03-16 | $11.57M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $3.31M 10-Q · filed 2022-11-10 | $5.82M derived: sum of 2 quarters · filed 2022-11-10 | $9.09M 10-Q · filed 2022-11-10 | $13.40M derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $2.50M 10-Q · filed 2022-08-11 | $5.78M 10-Q · filed 2022-08-11 | $10.09M derived: sum of 3 quarters · filed 2022-08-11 | $15.91M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $3.27M 10-Q · filed 2022-05-12 | $7.59M derived: sum of 2 quarters · filed 2022-05-12 | $13.41M derived: sum of 3 quarters · filed 2022-05-12 | $19.38M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $10.13M derived: sum of 2 quarters · filed 2022-03-24 | $16.11M derived: sum of 3 quarters · filed 2022-03-24 | $16.59M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $5.82M 10-Q · filed 2021-11-12 | $11.80M derived: sum of 2 quarters · filed 2021-11-12 | $12.28M 10-Q · filed 2021-11-12 | $12.33M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $5.98M 10-Q · filed 2021-08-12 | $8.34M 10-Q · filed 2020-08-13 | $6.46M 10-Q · filed 2021-08-12 | $8.83M 10-Q · filed 2020-08-13 | $6.51M derived: sum of 3 quarters · filed 2021-08-12 | $6.53M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $481.74K 10-Q · filed 2021-05-13 | $534.54K derived: sum of 2 quarters · filed 2021-05-13 | $554.91K derived: sum of 3 quarters · filed 2021-05-13 | $593.72K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $52.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $73.17K derived: sum of 2 quarters · filed 2021-03-25 | $111.98K derived: sum of 3 quarters · filed 2021-03-25 | $112.43K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $20.36K 10-Q · filed 2020-11-16 | $59.17K derived: sum of 2 quarters · filed 2020-11-16 | $59.63K 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $38.81K 10-Q/A · filed 2020-11-03 | $39.26K 10-Q/A · filed 2020-11-03 | |||||
| 2019-03-31 | $452.00 10-Q · filed 2020-05-14 | ||||||
| 2018-12-31 | $9.39K 10-K · filed 2020-03-30 | ||||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $302.00 derived: sum of 3 quarters · filed 2019-04-01 | $302.00 10-K · filed 2019-04-01 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $302.00 derived: sum of 2 quarters · filed 2018-11-14 | $302.00 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $302.00 10-Q · filed 2018-08-10 | $302.00 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |